Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
Abroad (travel likely)RecruitingPHASE2
Conditions
Breast Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, San Diego, La Jolla, California, United States
Study leads
Kay Yeung, MD, PhD
Principal Investigator
University of California, San Diego